Anti-POMK monoclonal antibody

Pre-made anti-POMK monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to POMK/POMK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1428-Ab-1/ GM-Tg-hg-IP1428-Ab-2Anti-Human POMK monoclonal antibodyHuman
GM-Tg-rg-IP1428-Ab-1/ GM-Tg-rg-IP1428-Ab-2Anti-Rat POMK monoclonal antibodyRat
GM-Tg-mg-IP1428-Ab-1/ GM-Tg-mg-IP1428-Ab-2Anti-Mouse POMK monoclonal antibodyMouse
GM-Tg-cynog-IP1428-Ab-1/ GM-Tg-cynog-IP1428-Ab-2Anti-Cynomolgus/ Rhesus macaque POMK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1428-Ab-1/ GM-Tg-felg-IP1428-Ab-2Anti-Feline POMK monoclonal antibodyFeline
GM-Tg-cang-IP1428-Ab-1/ GM-Tg-cang-IP1428-Ab-2Anti-Canine POMK monoclonal antibodyCanine
GM-Tg-bovg-IP1428-Ab-1/ GM-Tg-bovg-IP1428-Ab-2Anti-Bovine POMK monoclonal antibodyBovine
GM-Tg-equg-IP1428-Ab-1/ GM-Tg-equg-IP1428-Ab-2Anti-Equine POMK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1428-Ab-1/ GM-Tg-hg-IP1428-Ab-2; GM-Tg-rg-IP1428-Ab-1/ GM-Tg-rg-IP1428-Ab-2;
GM-Tg-mg-IP1428-Ab-1/ GM-Tg-mg-IP1428-Ab-2; GM-Tg-cynog-IP1428-Ab-1/ GM-Tg-cynog-IP1428-Ab-2;
GM-Tg-felg-IP1428-Ab-1/ GM-Tg-felg-IP1428-Ab-2; GM-Tg-cang-IP1428-Ab-1/ GM-Tg-cang-IP1428-Ab-2;
GM-Tg-bovg-IP1428-Ab-1/ GM-Tg-bovg-IP1428-Ab-2; GM-Tg-equg-IP1428-Ab-1/ GM-Tg-equg-IP1428-Ab-2
Products NameAnti-POMK monoclonal antibody
Formatmab
Target NamePOMK
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-POMK monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1428-Ag-1Recombinant multi-species SG196/ POMK/ MDDGA12 protein


    Target information

    Target IDGM-IP1428
    Target NamePOMK
    Gene ID84197,74653,306549,706318,482834,102902090,514490,100053457
    Gene Symbol and Synonyms4930444A02Rik,MDDGA12,MDDGC12,POMK,RGD1310810,SGK196
    Uniprot AccessionQ9H5K3,Q4V8A9
    Uniprot Entry NameSG196_HUMAN,SG196_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185900
    Target ClassificationKinase

    The target: POMK, gene name: POMK, also named as MDDGA12, MDDGC12, SGK196. This gene encodes a protein that may be involved in the presentation of the laminin-binding O-linked carbohydrate chain of alpha-dystroglycan (a-DG), which forms transmembrane linkages between the extracellular matrix and the exoskeleton. Some pathogens use this O-linked carbohydrate unit for host entry. Loss of function compound heterozygous mutations in this gene were found in a human patient affected by the Walker-Warburg syndrome (WWS) phenotype. Mice lacking this gene contain misplaced neurons (heterotopia) in some regions of the brain, possibly from defects in neuronal migration. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.